Shenzhen - Delayed Quote CNY
Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
3.4400
+0.0100
+(0.29%)
At close: May 23 at 3:04:33 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
357,012.6813
405,174.6613
420,643.6192
373,440.3568
315,134.2490
Cost of Revenue
247,326.9201
278,889.8307
285,645.9640
239,834.6978
195,758.0343
Gross Profit
109,685.7612
126,284.8306
134,997.6553
133,605.6591
119,376.2147
Operating Expense
120,839.7687
128,334.3910
161,037.0734
142,770.1920
242,351.5593
Operating Income
-11,154.0075
-2,049.5604
-26,039.4181
-9,164.5329
-122,975.3446
Net Non Operating Interest Income Expense
-13,495.1793
-19,297.8274
-33,429.0076
-41,212.6779
-46,835.2184
Pretax Income
29,678.3831
34,485.4948
-11,563.6776
-135,317.8426
-224,162.7027
Tax Provision
243.4278
245.7135
313.2883
-2,628.0875
4,117.6117
Net Income Common Stockholders
29,434.9553
34,239.7813
-11,876.9659
-132,689.7551
-228,280.3144
Basic EPS
0.04
--
-0.02
-0.25
-0.43
Diluted EPS
0.04
--
-0.02
-0.25
-0.43
Basic Average Shares
717,607.4920
--
593,848.2960
530,759.0200
530,884.4520
Diluted Average Shares
717,607.4920
--
593,848.2960
530,759.0200
530,884.4520
Total Operating Income as Reported
23,358.3753
28,155.4783
-63,453.2904
-116,574.5344
-199,342.1283
Rent Expense Supplemental
--
474.6627
265.4628
373.4509
1,387.7949
Total Expenses
368,166.6887
407,224.2217
446,683.0373
382,604.8898
438,109.5936
Net Income from Continuing & Discontinued Operation
29,434.9553
34,239.7813
-11,876.9659
-132,689.7551
-228,280.3144
Normalized Income
34,850.8682
38,176.9258
-7,362.6679
-67,151.7132
-201,692.6580
Interest Income
10,647.4306
11,301.4690
14,049.3181
11,143.7446
10,068.6495
Interest Expense
24,125.2257
30,590.2221
47,457.8305
52,311.1272
56,872.7887
Net Interest Income
-13,495.1793
-19,297.8274
-33,429.0076
-41,212.6779
-46,835.2184
EBIT
53,803.6089
65,075.7169
35,894.1529
-83,006.7153
-167,289.9140
EBITDA
53,803.6089
102,002.1652
74,599.2175
-41,392.7419
-123,512.1493
Reconciled Cost of Revenue
247,326.9201
278,889.8307
285,645.9640
239,834.6978
195,758.0343
Reconciled Depreciation
--
36,926.4483
38,705.0646
41,613.9734
43,777.7648
Net Income from Continuing Operation Net Minority Interest
29,434.9553
34,239.7813
-11,876.9659
-132,689.7551
-228,280.3144
Total Unusual Items Excluding Goodwill
-5,460.7026
-3,965.3984
-6,019.0641
-66,836.1052
-35,450.2086
Total Unusual Items
-5,460.7026
-3,965.3984
-6,019.0641
-66,836.1052
-35,450.2086
Normalized EBITDA
59,264.3114
105,967.5636
80,618.2816
25,443.3633
-88,061.9407
Tax Rate for Calcs
0
0
0.0003
0
0.0003
Tax Effect of Unusual Items
-44.7897
-28.2540
-1,504.7660
-1,298.0633
-8,862.5521
12/31/2021 - 3/16/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade